Bot-Fit
Asset
Wearable hip exoskeleton modifies walking mechanics to influence postprandial glucose responses.
- Stage
- Human trials
- Modality
- Device
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Type 2 diabetes
Human trials, Completed, NCT07692802, clinicaltrials.gov, 10 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors2
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.